Pharmacological therapy in children with atrial fibrillation and atrial flutter

Current Pharmaceutical Design

Volumn 14, Issue 8, 2008, Pages 770-775

  Fazio, Giovanni ^a,d   Visconti, Claudia ^b   D'Angelo, Luciana ^b   Novo, Giuseppina ^a   Barbaro, Giuseppe ^c   Novo, Salvatore ^a  

^a UNIVERSITY OF PALERMO   (Italy)

^b HARVARD UNIVERSITY   (United States)

^c SAPIENZA UNIVERSITY OF ROME   (Italy)

^d NONE   (Italy)

Author keywords

Atrial fibrillation; Atrial flutter; Children; Treatment

Indexed keywords

ADENOSINE; AMIODARONE; ANTIARRHYTHMIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM ANTAGONIST; DIGITALIS; FLECAINIDE; PROPAFENONE;

ANTIARRHYTHMIC ACTIVITY; CARDIOVERSION; CATHETER ABLATION; CHILD; CLINICAL FEATURE; CONGENITAL HEART DISEASE; CRYOABLATION; DISEASE CLASSIFICATION; DRUG DOSE INCREASE; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERABILITY; ECHOCARDIOGRAPHY; ELECTROCARDIOGRAPHY; HEART ATRIUM FIBRILLATION; HEART ATRIUM FLUTTER; HEART ATRIUM PACING; HUMAN; LONG TERM CARE; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROGNOSIS; RECURRENCE RISK; REVIEW; SUDDEN DEATH; SUPRAVENTRICULAR PREMATURE BEAT; UNSPECIFIED SIDE EFFECT;

ADRENERGIC BETA-ANTAGONISTS; ANTI-ARRHYTHMIA AGENTS; ATRIAL FIBRILLATION; ATRIAL FLUTTER; CALCIUM CHANNEL BLOCKERS; CARDIAC PACING, ARTIFICIAL; CATHETER ABLATION; CHILD; CHRONIC DISEASE; ELECTRIC COUNTERSHOCK; ELECTROCARDIOGRAPHY; HUMANS;

EID: 44349133922     PISSN: 13816128     EISSN: None     Source Type: Journal    
DOI: 10.2174/138161208784007707     Document Type: Review

References (23)

1. Rhodes L, Walsh E, Saul P. Conversion of atrial flutter in pediatric patienus by transesophageal atrial pacing: A sale, effective, minimally invasive procedure. Am Heart J 1995; 130: 323-7.
2. Kantoch M. Supraventricular tachycardia in children. Indian J Pediatr 2005; 72: 609-19.
3. Disertori M, Alboni P, Brignole M, Lunati M, Oreto G, Salemo J, et Al. Cardiac arrhythmia: Terminology update. G Ital Cardiol 1999; 29: 805-9
4. Andrew P, Montenero S. Atrial flutter: A fucos on treatment options for a common supraventricular tachyarrhythmia. J Cardiovasc Med (Hagerstown) 2007; 8: 558-67.
5. Von Bernuth G. Clinical significance and treatment of cardiac arrhythmia in children. Klin Pediatr 1990; 202: 1-10.
6. Vignati G. Pediatric arrhythimas: Which are the news? J Cardiovasc Med 2007; 8: 62-6.
7. Campbell RM, Strieper MJ, Frais PA, Danford DA, Kugler JD. Current status oi radiofrequency ablation for common pediatric supraventricular tachycardia. J Pediatr 2002; 140: 150-5.
8. Kirsh JA, Gross GJ, O'Connor S, Hamilton RM. Cryocath International Patient Registry. Transcatheter cryoablation of tachyarrhythimas in children: Initial experience from an international registry J Am Coll Cardiol 2005; 45: 133-6.
9. Wellens HJ. Contemporary management of atrial flutter. Circulation 2002; 106: 649-52.
10. Yamreudeewong W, DeBisschop M, Martin LG, Lower DL. Potennally significant drug interactions of class III antiarrhythmic drugs. Drug Saf 2003; 26: 421-38.
11. Nemec J, Shen WK. Antiarrhythmic drugs: New agents and evolving concepts. Expert Opin Investig Drugs 2003: 12: 435-53.
12. Natale A, Newby KH, Pisano E, Leonelli F, Farielli R, Potenza D, et al. Prospective randomized comparison of antiarrhythmic therapy versus firstline radiofrequency ablation in patients with atrial flutter. J Am Coll Cardiol 2000; 35: 1898-904.
13. CalKins H, Canby K, Weiss R, Taylor G, Wells P, Chinitz L, et al. Results of catheter ablation of typical atrial flutter. Am J Cardiol 2004; 94: 437-42.
14. Tracy CM, Akhtar M, DiMarco JP, Packer DL, Weitz HH, Winters WL, et al. American College of Cardiology/American Heart Association Clinical Competence Statement on invasive electrophysiology studies, catheter ablation, and cardioversion: A report ot the American College of Cardiology/American Heart Association/American College of Physicians-American Society of Internal Medicine Task Force on Clinical Competence. Circulation 2000; 102: 2309-20.
15. Bertaglia E, Zoppo F, Bonso A, Proclemer A, Verato R, Coro L, et al. Long term up of radiofrequency catheter ablation of atrial flutter: Clinical course and predictors of trial fibrillation occurrence. Heart 2004; 90: 59-63.
16. De Sisti A, Leclercq JF, Fiorello P, Palamara A, Atuel P. The effects of the ablation of atrial flutter in patients with and without a clinical history of paroxysmal atrial fibrillation. G Ital Cardiol 1998; 28: 1253-60.
17. Schmieder S, Ndrepepa G, Dong J, Zrenner B, Schreieck J, Schneider MA, et al. Acute and long-term results of radiofrequency ablation of common atrial flutter and the influence of the right atrial isthmus ablation on the occurrence of atrial fibrillation. Eur Heart J 2003; 24: 956-62.
18. Anne W, Willems R, Adriaenssens B, Adams J, Ector H, Heidbuchel H. Lona-term symptomatic benefit after radiofrequency catheter ablation for atrial flutter despite a high incidence of post-procedural atrial fibrillation. Acta Cardiol 2006; 61: 75-82.
19. Tucker KT, Wilson C. A comparison oi transoesophageal atrial pacing and direct current cardioversion for the termination of atrial flutter: A prospective, randomized clinical trial. Br Heart J 1993; 69: 530-5.
20. Crawford W, Plumb V, Epstien A, Kay GN. Prospective evaluation of transesophageal pacing for the interruption of atrial flutter. Am Ji Med 1989; 86: 663-7.
21. Guarnerio M, Furlanello F, Del Greco M, Vergara G, Inama G, Disertori M. Transesophageal atrial pacing: A first-choice technique in atrial flutter therapy. Am Heart J 1989; 117: 1241-52.
22. Volkmann H, Dannberg G, Heinke M, Kuhnert H. Termination of tachycardias by transesophageal electrical pacing. Pacing Clin Electrophysiol 1992; 15(Pt 2): 1962-6.
23. Disertori M. Transesophageal atrial stimulation in the treatment of atrial flutter. Its usefulness and limits. G Ital Cardiol 1993; 23: 281-3.